El-Serag, H.B. 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142 (1264–1273): e1.
Garg, A.D., D.V. Krysko, P. Vandenabeele, and P. Agostinis. 2012. The emergence of phox-ER stress induced immunogenic apoptosis. Oncoimmunology 1: 786–788.
Article PubMed PubMed Central Google Scholar
Peters, M., S. Wellek, H.P. Dienes, T. Junginger, J. Meyer, K.H. Meyer Zum Buschendfelde, et al. 1994. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. Zeitschrift fur Gastroenterologie 32: 146–151.
Miller, J.F., and M. Sadelain. 2015. The journey from discoveries in fundamental immunology to cancer immunotherapy. Cancer Cell 27: 439–449.
Yu, L.Y., J. Tang, C.M. Zhang, W.J. Zeng, H. Yan, M.P. Li, et al. 2017. New immunotherapy strategies in breast cancer. International journal of environmental research and public health 14: 14.
Moris, D., E.W. Beal, J. Chakedis, R.A. Burkhart, C. Schmidt, M. Dillhoff, et al. 2017. Role of exosomes in treatment of hepatocellular carcinoma. Surgical oncology 26: 219–228.
Palmer, D.H., R.S. Midgley, N. Mirza, E.E. Torr, F. Ahmed, J.C. Steele, et al. 2009. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology 49: 124–132.
Butterfield, L.H., A. Ribas, V.B. Dissette, Y. Lee, J.Q. Yang, P. De la Rocha, et al. 2006. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. Clinical cancer research : An official journal of the American Association for Cancer Research 12: 2817–2825.
Zeng, Y., H. Feng, M.W. Graner, and E. Katsanis. 2003. Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. Blood 101: 4485–4491.
Pusztai, L., T. Karn, A. Safonov, M.M. Abu-Khalaf, and G. Bianchini. 2016. New strategies in breast cancer: Immunotherapy. Clinical cancer research : An official journal of the American Association for Cancer Research 22: 2105–2110.
Ma, Y., G.V. Shurin, D.W. Gutkin, and M.R. Shurin. 2012. Tumor associated regulatory dendritic cells. Seminars in cancer biology 22: 298–306.
Article PubMed PubMed Central Google Scholar
Ueno, H., E. Klechevsky, R. Morita, C. Aspord, T. Cao, T. Matsui, et al. 2007. Dendritic cell subsets in health and disease. Immunological eviews 219: 118–142.
Osorio, F., C. Fuentes, M.N. Lopez, F. Salazar-Onfray, and F.E. Gonzalez. 2015. Role of dendritic cells in the induction of lymphocyte tolerance. Frontiers in mmunology 6: 535.
Fan, L., G. Sun, T. Ma, F. Zhong, Y. Lei, X. Li, et al. 2013. Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin. Journal of ineal research 55: 184–194.
Graner, M.W., K.O. Lillehei, and E. Katsanis. 2014. Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines. Frontiers in ncology 4: 379.
Chen, W., J. Wang, C. Shao, S. Liu, Y. Yu, Q. Wang, et al. 2006. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. European ournal of immunology 36: 1598–1607.
Lee, B.R., S.Y. Chang, E.H. Hong, B.E. Kwon, H.M. Kim, Y.J. Kim, et al. 2014. Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells. Oncotarget 5: 12331–12345.
Article PubMed PubMed Central Google Scholar
Montico B, Nigro A, Casolaro V, Dal Col J. 2018. Immunogenic apoptosis as a novel tool for anticancer vaccine development. International Journal of Molecular Sciences 19 (2): 594.
Hodge, J.W., C.T. Garnett, B. Farsaci, C. Palena, K.Y. Tsang, S. Ferrone, et al. 2013. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. International ournal of cancer 133: 624–636.
Lv, L.H., Y.L. Wan, Y. Lin, W. Zhang, M. Yang, G.L. Li, et al. 2012. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. The Journal of Biological chemistry 287: 15874–15885.
Article PubMed PubMed Central Google Scholar
van der Pol, E., A.N. Boing, P. Harrison, A. Sturk, and R. Nieuwland. 2012. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacological eviews 64: 676–705.
Rao, Q., B. Zuo, Z. Lu, X. Gao, A. You, C. Wu, et al. 2016. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology 64: 456–472.
Wolfers, J., A. Lozier, G. Raposo, A. Regnault, C. Thery, C. Masurier, et al. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nature medicine 7: 297–303.
Dai, S., X. Zhou, B. Wang, Q. Wang, Y. Fu, T. Chen, et al. 2006. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells. Journal of Molecular Medicine 84: 1067–1076.
Liu, J., L. Fan, H. Yu, J. Zhang, Y. He, D. Feng, et al. 2019. Endoplasmic reticulum stress causes liver cancer cells to release exosomal miR-23a-3p and up-regulate programmed death ligand 1 expression in macrophages. Hepatology 70: 241–258.
Li, R., F. Fang, M. Jiang, C. Wang, J. Ma, W. Kang, et al. 2017. STAT3 and NF-kappaB are simultaneously suppressed in dendritic cells in lung cancer. Scientific Reports 7: 45395.
Article PubMed PubMed Central Google Scholar
Blom, K.G., M.R. Qazi, J.B. Matos, B.D. Nelson, J.W. DePierre, and M. Abedi-Valugerdi. 2009. Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtained. Clinical and Experimental mmunology 155: 320–329.
Adamowicz, J., T. Kloskowski, J. Tworkiewicz, M. Pokrywczynska, and T. Drewa. 2012. Urine is a highly cytotoxic agent: Does it influence stem cell therapies in urology? Transplantation roceedings 44: 1439–1441.
Wang, L., Y. Huang, X. Wang, and Y. Chen. 2019. Label-Free LC-MS/MS proteomics analyses reveal proteomic changes accompanying MSTN KO in C2C12 Cells. BioMed Research International 2019: 7052456.
PubMed PubMed Central Google Scholar
Langenkamp, A., M. Messi, A. Lanzavecchia, and F. Sallusto. 2000. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nature mmunology 1: 311–316.
Felzmann, T., K.G. Huttner, S.K. Breuer, D. Wimmer, G. Ressmann, D. Wagner, et al. 2005. Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses. Cancer Immunology, mmunotherapy : CII 54: 769–780.
Fucikova, J., P. Kralikova, A. Fialova, T. Brtnicky, L. Rob, J. Bartunkova, et al. 2011. Human tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer esearch 71: 4821–4833.
Clarke, H.J., J.E. Chambers, E. Liniker, and S.J. Marciniak. 2014. Endoplasmic reticulum stress in malignancy. Cancer Cell 25: 563–573.
Brewer, J.W., and J.A. Diehl. 2000. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proceedings of the National Academy of Sciences of the United States of America 97: 12625–12630.
Article PubMed PubMed Central Google Scholar
Andre, F., N.E. Schartz, M. Movassagh, C. Flament, P. Pautier, P. Morice, et al. 2002. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295–305.
Hickman-Miller, H.D., and W.H. Hildebrand. 2004. The immune response under stress: The role of HSP-derived peptides. Trends in mmunology 25: 427–433.
Spisek, R., A. Charalambous, A. Mazumder, D.H. Vesole, S. Jagannath, and M.V. Dhodapkar. 2007. Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: Therapeutic implications. Blood 109: 4839–4845.
Article PubMed PubMed Central Google Scholar
Rakoff-Nahoum, S., and R. Medzhitov. 2009. Toll-like receptors and cancer. Nature Reviews ancer 9: 57–63.
Zitvogel, L., O. Kepp, and G. Kroemer. 2011. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nature Reviews Clinical Oncology 8: 151–160.
留言 (0)